BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alzaid F, Julla JB, Diedisheim M, Potier C, Potier L, Velho G, Gaborit B, Manivet P, Germain S, Vidal-Trecan T, Roussel R, Riveline JP, Dalmas E, Venteclef N, Gautier JF. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes. EMBO Mol Med 2020;12:e13038. [PMID: 32816392 DOI: 10.15252/emmm.202013038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Ni J, Qiu LJ, Yin KJ, Chen GM, Pan HF. Shared genetic architecture between type 2 diabetes and COVID-19 severity. J Endocrinol Invest 2022. [PMID: 36127482 DOI: 10.1007/s40618-022-01920-5] [Reference Citation Analysis]
2 Aznaourova M, Schmerer N, Janga H, Zhang Z, Pauck K, Bushe J, Volkers SM, Wendisch D, Georg P, Ntini E, Aillaud M, Gündisch M, Mack E, Skevaki C, Keller C, Bauer C, Bertrams W, Marsico A, Nist A, Stiewe T, Gruber AD, Ruppert C, Li Y, Garn H, Sander LE, Schmeck B, Schulte LN. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19. Proc Natl Acad Sci U S A 2022;119:e2120680119. [PMID: 35998224 DOI: 10.1073/pnas.2120680119] [Reference Citation Analysis]
3 Ulloque-badaracco JR, Alarcon-braga EA, Hernandez-bustamante EA, Al-kassab-córdova A, Mosquera-rojas MD, Ulloque-badaracco RR, Huayta-cortez MA, Maita-arauco SH, Herrera-añazco P, Benites-zapata VA. Fibrinogen-to-Albumin Ratio and Blood Urea Nitrogen-to-Albumin Ratio in COVID-19 Patients: A Systematic Review and Meta-Analysis. TropicalMed 2022;7:150. [DOI: 10.3390/tropicalmed7080150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Al-sayyar A, Hulme KD, Thibaut R, Bayry J, Sheedy FJ, Short KR, Alzaid F. Respiratory Tract Infections in Diabetes – Lessons From Tuberculosis and Influenza to Guide Understanding of COVID-19 Severity. Front Endocrinol 2022;13:919223. [DOI: 10.3389/fendo.2022.919223] [Reference Citation Analysis]
5 Cariou B, Wargny M, Boureau AS, Smati S, Tramunt B, Desailloud R, Lebeault M, Amadou C, Ancelle D, Balkau B, Bordier L, Borot S, Bourgeon M, Bourron O, Cosson E, Eisinger M, Gonfroy-Leymarie C, Julla JB, Marchand L, Meyer L, Seret-Bégué D, Simon D, Sultan A, Thivolet C, Vambergue A, Vatier C, Winiszewski P, Saulnier PJ, Bauduceau B, Gourdy P, Hadjadj S; CORONADO investigators. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative. Diabetologia 2022. [PMID: 35701673 DOI: 10.1007/s00125-022-05734-1] [Reference Citation Analysis]
6 Degarege A, Naveed Z, Kabayundo J, Brett-major D. Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis. Pathogens 2022;11:563. [DOI: 10.3390/pathogens11050563] [Reference Citation Analysis]
7 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Palaiodimos L, Ali R, Teo HO, Parthasarathy S, Karamanis D, Chamorro-Pareja N, Kokkinidis DG, Kaur S, Kladas M, Sperling J, Chang M, Hupart K, Cha-Fong C, Srinivasan S, Kishore P, Davis N, Faillace RT. Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City. J Clin Med 2022;11:622. [PMID: 35160073 DOI: 10.3390/jcm11030622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sabri S, Bourron O, Phan F, Nguyen LS. Interactions between diabetes and COVID-19: A narrative review. World J Diabetes 2021; 12(10): 1674-1692 [PMID: 34754370 DOI: 10.4239/wjd.v12.i10.1674] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Marfella R, D'Onofrio N, Sardu C, Scisciola L, Maggi P, Coppola N, Romano C, Messina V, Turriziani F, Siniscalchi M, Maniscalco M, Boccalatte M, Napolitano G, Salemme L, Marfella LV, Basile E, Montemurro MV, Papa C, Frascaria F, Papa A, Russo F, Tirino V, Papaccio G, Galdiero M, Sasso FC, Barbieri M, Rizzo MR, Balestrieri ML, Angelillo IF, Napoli C, Paolisso G. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes Obes Metab 2021. [PMID: 34494705 DOI: 10.1111/dom.14547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 15.0] [Reference Citation Analysis]
12 Lasbleiz A, Gaborit B, Soghomonian A, Bartoli A, Ancel P, Jacquier A, Dutour A. COVID-19 and Obesity: Role of Ectopic Visceral and Epicardial Adipose Tissues in Myocardial Injury. Front Endocrinol (Lausanne) 2021;12:726967. [PMID: 34484128 DOI: 10.3389/fendo.2021.726967] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
13 Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Federico L, de Biase D, Zippi M, Zancanaro M. COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Cytokine 2021;148:155628. [PMID: 34411989 DOI: 10.1016/j.cyto.2021.155628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Kaminska H, Szarpak L, Kosior D, Wieczorek W, Szarpak A, Al-Jeabory M, Gawel W, Gasecka A, Jaguszewski MJ, Jarosz-Chobot P. Impact of diabetes mellitus on in-hospital mortality in adult patients with COVID-19: a systematic review and meta-analysis. Acta Diabetol 2021;58:1101-10. [PMID: 33778910 DOI: 10.1007/s00592-021-01701-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
15 Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay-Ramírez KA, Meza-Robles C, Lopez-Flores R, Delgado-Machuca M, Murillo-Zamora E, Toscano-Velazquez JA, Delgado-Enciso J, Melnikov V, Walle-Guillen M, Galvan-Salazar HR, Delgado-Enciso OG, Cabrera-Licona A, Danielewicz-Mata EJ, Mandujano-Diaz PJ, Guzman-Esquivel J, Montes-Galindo DA, Perez-Martinez H, Jimenez-Villegaz JM, Hernandez-Rangel AE, Montes-Diaz P, Rodriguez-Sanchez IP, Martinez-Fierro ML, Garza-Veloz I, Tiburcio-Jimenez D, Zaizar-Fregoso SA, Gonzalez-Alcaraz F, Gutierrez-Gutierrez L, Diaz-Lopez L, Ramirez-Flores M, Guzman-Solorzano HP, Gaytan-Sandoval G, Martinez-Perez CR, Espinoza-Gómez F, Rojas-Larios F, Hirsch-Meillon MJ, Baltazar-Rodriguez LM, Barrios-Navarro E, Oviedo-Rodriguez V, Mendoza-Hernandez MA, Prieto-Diaz-Chavez E, Paz-Michel BA. Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial. Exp Ther Med 2021;22:915. [PMID: 34306189 DOI: 10.3892/etm.2021.10347] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Peña KB, Riu F, Gumà J, Guilarte C, Pique B, Hernandez A, Àvila A, Parra S, Castro A, Rovira C, Cueto P, Vallverdu I, Parada D. Study of the Plasma and Buffy Coat in Patients with SARS-CoV-2 Infection-A Preliminary Report. Pathogens 2021;10:805. [PMID: 34201967 DOI: 10.3390/pathogens10070805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Klonoff DC, Messler J, Valk T, Jagannathan R, Pasquel FJ, Umpierrez GE. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia. J Diabetes Sci Technol 2021;15:1181-7. [PMID: 34159841 DOI: 10.1177/19322968211013369] [Reference Citation Analysis]
18 Paolini A, Borella R, De Biasi S, Neroni A, Mattioli M, Lo Tartaro D, Simonini C, Franceschini L, Cicco G, Piparo AM, Cossarizza A, Gibellini L. Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19. Cells 2021;10:1585. [PMID: 34201847 DOI: 10.3390/cells10071585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li Y, Mateu E. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells. Front Immunol 2021;12:674185. [PMID: 34177915 DOI: 10.3389/fimmu.2021.674185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Koufakis T, Dimitriadis G, Metallidis S, Zebekakis P, Kotsa K. The role of autoimmunity in the pathophysiology of type 2 diabetes: Looking at the other side of the moon. Obes Rev 2021;22:e13231. [PMID: 33682984 DOI: 10.1111/obr.13231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Dhar SK, Sachdeva K, Das M. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis. Diabetes Metab Syndr 2021;15:639-41. [PMID: 33676871 DOI: 10.1016/j.dsx.2021.02.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Najm A, Alunno A, Mariette X, Terrier B, De Marco G, Emmel J, Mason L, McGonagle DG, Machado PM. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider. RMD Open 2021;7:e001549. [PMID: 33574116 DOI: 10.1136/rmdopen-2020-001549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group. A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med 2021;59:1315-22. [PMID: 33606928 DOI: 10.1515/cclm-2020-1801] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab 2021;33:479-98. [PMID: 33529600 DOI: 10.1016/j.cmet.2021.01.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 75] [Article Influence: 30.0] [Reference Citation Analysis]
26 Ishikawa G, Argenti G, Fadel CB. Non-specific blood tests as proxies for COVID-19 hospitalisation: are there plausible associations after excluding noisy predictors? Epidemiol Infect 2021;149:e23. [PMID: 33427157 DOI: 10.1017/S0950268821000078] [Reference Citation Analysis]
27 Alzaid F, Julla JB, Diedisheim M, Potier C, Potier L, Velho G, Gaborit B, Manivet P, Germain S, Vidal-Trecan T, Roussel R, Riveline JP, Dalmas E, Venteclef N, Gautier JF. Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes. EMBO Mol Med 2020;12:e13038. [PMID: 32816392 DOI: 10.15252/emmm.202013038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
28 Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay-Ramírez KA, Meza-Robles C, Lopez-Flores R, Delgado-Machuca M, Murillo-Zamora E, Toscano-Velazquez JA, Delgado-Enciso J, Melnikov V, Walle-Guillen M, Galvan-Salazar HR, Delgado-Enciso OG, Cabrera-Licona A, Guzman-Esqu J, Montes-Galindo DA, Hernandez-Rangel AE, Montes-Diaz P, Rodriguez-Sanchez IP, Martinez-Fierro ML, Garza-Veloz I, Tiburcio-Jimenez D, Zaizar-Fregoso SA, Ramirez-Flores M, Gaytan-Sandoval G, Martinez-Perez CR, Espinoza-Gómez F, Rojas-Larios F, Hirsch-Meillon MJ, Barrios-Navarro E, Oviedo-Rodriguez V, Rodriguez LMB, Paz-Michel BA. Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial. Res Sq 2020:rs. [PMID: 32935090 DOI: 10.21203/rs.3.rs-68403/v1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]